#biotech

Last 24h 📊 Neutral 📈3 📉1 📊4

Last 7 Days 📊 Neutral 📈11 📉4 📊21

Last 30 Days 📊 Neutral 📈79 📉9 📊81

News 📈 Stocks

Novartis Shares Slump 13% on Failed Clinical Trial, Amgen Drops 9%

September 10, 2026 (61 days ago)

Novartis shares plummeted 13% following a failed clinical trial for del-desiran, while Amgen shares dropped 9% on contagion fears, pressuring the Dow…

AMGN DJIA

🌍 NORTH AMER Read More →

News 📈 Stocks

LB Pharmaceuticals Stock Triples as Investors Eye Takeover Potential

September 9, 2026 (62 days ago)

Shares of LB Pharmaceuticals have surged over 200% in the last year, fueled by optimism surrounding its proprietary oral benzamide formulation and…

BMY JNJ

🌍 NORTH AMER Read More →

News 📈 Stocks

Moderna Shares Surge 499% Over 52 Weeks on Cancer Vaccine Breakthrough

September 9, 2026 (62 days ago)

Moderna stock maintains strong bullish momentum, surging 499.5% annually after its cancer vaccine trial met key clinical goals, leaving sector peers like…

MRNA XLV MRK

🌍 NORTH AMER Read More →

News 🏛 Indices

Dyne Therapeutics Shares Plunge 31% in Premarket Trading

September 8, 2026 (63 days ago)

Dyne Therapeutics shares fell 31% in premarket trading on no confirmed news, decoupling from the broader market as investors await further updates…

DJI ^GSPC NDX

🌍 NORTH AMER Read More →

News 📈 Stocks

Ionis Pharmaceuticals Shares Slide 13% Following Failed Phase 3 Drug Trial

September 8, 2026 (63 days ago)

Ionis Pharmaceuticals stock hit near 52-week lows after the Phase 3 trial for its cardiovascular drug pelacarsen failed to meet primary endpoints,…

^GSPC DJI NDX

🌍 NORTH AMER Read More →

News 🏛 Indices

Biohaven Shares Slip 1.9% as RBC Downgrades Stock to Sector Perform

September 8, 2026 (63 days ago)

Biohaven shares fell 1.9% as RBC lowered its price target to $19, citing valuation concerns and clinical risks ahead of a critical…

^GSPC DJI

🌍 NORTH AMER Read More →

News 📈 Stocks

Amgen Shares Slip 4.7% Following Novartis Trial Results and BMO Downgrade

September 8, 2026 (63 days ago)

Amgen stock dropped 4.7% amid broader market weakness, a BMO downgrade, and investor concerns regarding the clinical efficacy of Lp(a)-lowering treatments following…

AMGN SPX DJI

🌍 NORTH AMER Read More →

News 📈 Stocks

Vaxcyte CEO Sells 6,289 Shares for Taxes as Phase 3 Data Approaches

September 8, 2026 (63 days ago)

Vaxcyte CEO Grant Pickering offloaded shares for tax purposes, leaving investors focused on the upcoming Q4 readout of the VAX-31 trial, which…

PFE MRK ^GSPC +1

🌍 NORTH AMER Read More →

News 📈 Stocks

Moderna Surges 177% as Healthcare Sector Defies Drug Pricing Headwinds

September 7, 2026 (63 days ago)

Healthcare stocks remain a defensive stronghold as Moderna's clinical success, Pharvaris's upcoming trial data, and AbbVie's dividend reliability offer distinct opportunities for…

MRNA ABBV MRK +1

🌍 NORTH AMER Read More →

News 📈 Stocks

CSL Shares Post Biggest One-Day Surge Since 2001 After Upbeat Outlook

August 18, 2026 (84 days ago)

CSL shares surged the most since 2001 after the Australian plasma giant guided to 2027 NPAT growth of approximately 5% at constant…

CSL

🌍 AU Read More →

News 📈 Stocks

Non-Opioid Painkiller Developer Latigo Edges Higher After IPO

August 7, 2026 (94 days ago)

Shares of non-opioid painkiller maker Latigo rose modestly after its upsized IPO, signaling investor interest in the biotech's pain management solutions.

LTGO

🌍 US Read More →

News 📈 Stocks

BlossomHill's $150 Million IPO Priced, Backed by Janus Henderson

August 7, 2026 (95 days ago)

BlossomHill's $150 million IPO, backed by Janus Henderson, underscored biotech demand and could lift Janus Henderson's stock on the back of a…

JHG

🌍 US Read More →